These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

566 related items for PubMed ID: 16472872

  • 21. Induction of a Th-1-biased IgG subclass response against equine herpesvirus type 1 in horses previously infected with type 4 virus.
    Bannai H, Tsujimura K, Kondo T, Nemoto M, Yamanaka T, Sugiura T, Maeda K, Matsumura T.
    J Vet Med Sci; 2011 Apr; 73(4):535-9. PubMed ID: 21139350
    [Abstract] [Full Text] [Related]

  • 22. Equine herpesvirus-1 infection induces IFN-gamma production by equine T lymphocyte subsets.
    Breathnach CC, Soboll G, Suresh M, Lunn DP.
    Vet Immunol Immunopathol; 2005 Feb 10; 103(3-4):207-15. PubMed ID: 15621307
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A review of equid herpesvirus 1 for the veterinary practitioner. Part A: clinical presentation, diagnosis and treatment.
    Dunowska M.
    N Z Vet J; 2014 Jul 10; 62(4):171-8. PubMed ID: 24597778
    [Abstract] [Full Text] [Related]

  • 25. Inoculation of mares and very young foals with EHV-1 glycoproteins D and B reduces virus shedding following respiratory challenge with EHV-1.
    Foote CE, Raidal SL, Pecenpetelovska G, Wellington JE, Whalley JM.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):97-108. PubMed ID: 16504306
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Nasal shedding of equine herpesvirus-1 from horses in an outbreak of equine herpes myeloencephalopathy in Western Canada.
    Burgess BA, Tokateloff N, Manning S, Lohmann K, Lunn DP, Hussey SB, Morley PS.
    J Vet Intern Med; 2012 May 15; 26(2):384-92. PubMed ID: 22332764
    [Abstract] [Full Text] [Related]

  • 29. Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV types 1 and 4 challenges.
    Patel JR, Földi J, Bateman H, Williams J, Didlick S, Stark R.
    Vet Microbiol; 2003 Mar 20; 92(1-2):1-17. PubMed ID: 12488066
    [Abstract] [Full Text] [Related]

  • 30. Monitoring and detection of acute viral respiratory tract disease in horses.
    Mumford EL, Traub-Dargatz JL, Salman MD, Collins JK, Getzy DM, Carman J.
    J Am Vet Med Assoc; 1998 Aug 01; 213(3):385-90. PubMed ID: 9702229
    [Abstract] [Full Text] [Related]

  • 31. Equine herpesvirus type-1 modulates CCL2, CCL3, CCL5, CXCL9, and CXCL10 chemokine expression.
    Wimer CL, Damiani A, Osterrieder N, Wagner B.
    Vet Immunol Immunopathol; 2011 Apr 15; 140(3-4):266-74. PubMed ID: 21349590
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Equine herpesviruses type 1 (EHV-1) and 4 (EHV-4)--masters of co-evolution and a constant threat to equids and beyond.
    Ma G, Azab W, Osterrieder N.
    Vet Microbiol; 2013 Nov 29; 167(1-2):123-34. PubMed ID: 23890672
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Impact of the host immune response on the development of equine herpesvirus myeloencephalopathy in horses.
    Giessler KS, Goehring LS, Jacob SI, Davis A, Esser MM, Lee Y, Zarski LM, Weber PSD, Hussey GS.
    J Gen Virol; 2024 May 29; 105(5):. PubMed ID: 38767608
    [Abstract] [Full Text] [Related]

  • 36. EHV-1 and EHV-4 infection in vaccinated mares and their foals.
    Foote CE, Love DN, Gilkerson JR, Wellington JE, Whalley JM.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):41-6. PubMed ID: 16513181
    [Abstract] [Full Text] [Related]

  • 37. Report of the equine herpesvirus-1 Havermeyer Workshop, San Gimignano, Tuscany, June 2004.
    Slater JD, Lunn DP, Horohov DW, Antczak DF, Babiuk L, Breathnach C, Chang YW, Davis-Poynter N, Edington N, Ellis S, Foote C, Goehring L, Kohn CW, Kydd J, Matsumura T, Minke J, Morley P, Mumford J, Neubauer T, O'Callaghan D, Osterrieder K, Reed S, Smith K, Townsend H, van der Meulen K, Whalley M, Wilson WD.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):3-13. PubMed ID: 16542736
    [Abstract] [Full Text] [Related]

  • 38. Frequency and phenotype of EHV-1 specific, IFN-gamma synthesising lymphocytes in ponies: the effects of age, pregnancy and infection.
    Paillot R, Daly JM, Luce R, Montesso F, Davis-Poynter N, Hannant D, Kydd JH.
    Dev Comp Immunol; 2007 May 15; 31(2):202-14. PubMed ID: 16824599
    [Abstract] [Full Text] [Related]

  • 39. ADCC and complement-dependent lysis as immune mechanisms against EHV-1 infection in the horse.
    Stokes A, Wardley RC.
    Res Vet Sci; 1988 May 15; 44(3):295-302. PubMed ID: 2841731
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.